Cholecystitis Clinical Trial
Official title:
Randomized, Double-blind, Controlled Trial of Harmonic(H) Versus Monopolar Diathermy (M) for Laparoscopic Cholecystectomy (LC) for Acute Cholecystitis (AC) in Adults.
In the developmental stage of laparoscopic cholecystectomy it was considered 'unsafe' or
'technically difficult' to perform laparoscopic cholecystectomy for acute cholecystitis.
With increasing experience in laparoscopic surgery, a number of centers have reported on the
use of laparoscopic cholecystectomy for acute cholecystitis, suggesting that it is
technically feasible but at the expense of a high conversion rate, which can be up to 35 per
cent and common bile duct lesions.
The HARMONIC SCALPEL® (H) is the leading ultrasonic cutting and coagulating surgical device,
offering surgeons important benefits including: minimal lateral thermal tissue damage,
minimal charring and desiccation.
H technology reduces the need for ligatures with simultaneous cutting and coagulation:
moreover there is not electricity to or through the patient H has a greater precision near
vital structures and it produces minimal smoke with improved visibility in the surgical
field.
In retrospective series LC performed with H was demonstrated feasible and effective with
minimal operating time and blood loss: it was reported also a low conversion rate (3.9%).
However there are not prospective randomized controlled trials showing the advantages of H
compared to MD (the commonly used electrical scalpel) in LC.
Aim of this RCT is to demonstrate that H can reduce conversion rate compared to MD in LC for
AC.
DESIGN
The study project is a prospective, randomized investigation. The study will be performed in
the Department of Emergency Surgery St Orsola-Malpighi University Hospital (Bologna, Italy),
a large teaching institutions, with the participation of all surgeons who accept to be
involved in.
The patients will be divided in two groups: in the first group the patient will be submitted
to early LC within 72 hours after the diagnosis with H while in the second group will be
submitted to early LC within 72 hours with MD.
HOW RANDOMIZED
The randomization will be obtained through computer-generated schedule. The result of this
randomization will be sealed in numbered envelopes. After cholecystitis diagnosis if the
patient fulfils the inclusion criteria the responsible surgeon will ask the patient to
participate to the study. If the patient agree, he/ she will sign the informed consent.
After patient's consent the randomization will be carried out. The responsible surgeon will
record the patient name (and number).
All eligible patients will be recorded.
STATISTICS
POWER CALCULATIONS:
Sample size has been calculated to reach a confidence level of 95% with a power of 80%.A
sample size of 42 patients is calculated supposing that the hospital stay for LC with H the
conversion rate can be reduced from 35% to 3%. The sample size will be 21 patients for each
group (42 patients for the whole study).For comparison of the two groups, chi-square
analysis and Fisher's exact test are used when appropriate for qualitative data, and the
Student t-test (for normal variables) or the Mann Whitney U-test (for nonnormal variables)
for quantitative data. For multivariate analysis the stepwise logistic regression is
applied. A probability of 0.05 or less is accepted as statistically significant.
INTERVENTION
Preoperative data collected will include patient demographics and comorbid conditions
(genitourinary, cardiac, pulmonary, gastrointestinal, renal, or rheumatologic) and a
detailed history of symptom onset.
The procedure was performed by a surgeon that had performed at least 50 LCs. On admission,
the patients were started on cefotaxime, 2 g IV every 12h, which was continued
postoperatively according to NNISS score.
The standard four-trocar operative technique is used for LC for acute cholecystitis.
When the gallbladder is distended it will be first aspirated. To allow a good hold on the
gallbladder larger graspers will be inserted through a 5 mm right lower port. The cystic
artery and duct are clip-ligated in the MD group whereas in the H group cystic artery and
duct are closed by H. In the H group the surgeon will use only H, whereas in the MD group
the surgeon will use only MD. The gallbladder and intraperitoneal "dropped" stones are
collected in an endoscopic bag and extracted through the umbilical cannula site, which can
be extended. A closed system suction drain is left. Fascial closure is attempted only at the
umbilical cannula site. The skin at all the cannula sites are closed with staples.
Conversion to laparotomy will be decided by the operating surgeon and each conversion will
be motivated.
Data Collection Patients' data sheets are generated containing demographic data and
preoperative, operative, and postoperative information.
Pre-operative notes concern the history of gallbladder stones, the presence of associated
diseases (cardiac, hypertension, diabetes, malignancy), duration of gallbladder complaints
(as an indication for the onset of the disease), finding of a palpable gallbladder,
temperature, and laboratory results of WBC count, serum bilirubin, gamma GT, PCR, IL-6 and
alkaline phosphatase.
Ultrasound findings are also reported. Operative data of concern are macroscopic findings
(of acute cholecystitis, gangrenous cholecystitis, hydrops, and empyema of the gallbladder),
the presence of small stones (< 1 cm diameter) or large bile stones (> 1 cm diameter),
information regarding perforation of the gallbladder and intraperitoneally "lost" stones,
reasons for con¬version, and duration of surgery. Postoperative notes of interest included
the use of nasogastric tubes and drains, the amount of analgesics used, (evaluation of pain
with VAS score), complications, and length of hospital stay.
Complications are classified as surgical infections (wound infection, subphrenic or
subhepatic abscess); noninfectious surgi¬cal problems (e.g., bile duct injury, hemorrhage);
remote infec¬tions (urinary or respiratory); and miscellaneous problems (e.g., atelectasis,
deep vein thrombosis, AMI, CVA, etc). The collected information are entered into a database
as either continuous or categorical variables for statistical analysis. Following the
operative procedure, a normal sterile dressing will be applied to cover the abdomen.
A second surgical team, aware of the operative findings but not the surgical dissection
instrument, then will assume the care of the patient. Postoperative care and ability to be
discharged from the hospital will be determined by the second surgical team. The primary
operative team will be in every moment available for emergent consultation.
Patient discharge will be base on good medical practice criteria: 1) apyrexia 2) absence of
diseases requiring hospitalisation 3) return of bowel function 4) patient's compliance.
- IS THERE A PLACEBO? No
- INFORMED CONSENT TO BE SOUGHT? Yes (see: Case Report Form)
- INFORMED CONSENT FORM OR INFORMATION SHEET? Yes (see: Case Report Form).
In the informed consent form, patients will receive all the information about the study
protocol, the confidential nature of personal data and will fill up a questionnaire before
signing or refuse.
There will be not inconveniences caused to the patients. No incentives are planned for the
patients regarding the operation or the follow-up.
All the medical informations obtained from the patients will be kept confidentially among
the research scientists conducting the study.
The patients will be free to withdraw from the study, whenever they want without any
obligation.
STOPPING RULES
In case of newly discovered statistically significant advantages in one group.
PRIMARY ENDPOINTS
The aim of the study is to demonstrate that H can reduce conversion rate compared to MD in
LC for AC but also differences in terms of morbidity, mortality, operation time, hospital
stay, postoperative pain, return to normal activity will be evaluated.
The primary endpoints of our study will be:
- To evaluate the conversion rate
- To evaluate morbidity, mortality, operation time
- To evaluate hospital stay, postoperative pain, return to normal activity
The onset of any other complications will be recorded intraoperatively, postoperatively, at
discharge, at 7-days, 1-month and 6-months.
- PLANNED SUBGROUP ANALYSES? No.
- SIDE EFFECTS QUANTIFICATION? Yes There are not different side effects
- IS THERE AN ANALYSIS PLAN? Yes All the above mentioned data will be recorded in the
Case Report Form (annexed to this proposal) and later stored in computer database. At
the end of the study the final statistical examination will be carried out.
- ARE THERE PLANS FOR INTERIM ANALYSIS? Yes An interim statistical examination of the
data will be done every 3 months during the period of patients' inclusion in the study.
Then at the end of every completed follow-up period (1-month, 6-months).
- ARE THERE AN INDEPENDENT DATA-MONITORING COMITTEE? No
TYPE OF ANALYSIS
The statistical analysis will be carried out using Epi Info 2000, Version 1.1 software
package (Dean AG, Arner TG, Sangam S, Sunki GG, Friedman R, Lantinga M, Zubieta JC, Sullivan
KM, Smith DC. Epi Info 2000, a database and statistics program for public health
professionals for use on Windows 95, 98, NT, and 2000 computers; Centers for Disease Control
and Prevention, Atlanta, Georgia, USA, 2000).
INDEMNITIES SPECIFIED
No incentives are planned for the patients regarding the operation or the follow-up.
FINISHING DATE
The study will take approximately 6 months - 1 year for the inclusion period. According to
the number of AC managed monthly, the duration of the inclusion period can be approximately
of 1 year to reach the number of about 42 enrolled patients.
REPORTING DATE
An interim report is planned at the end of any completed follow-up period.
- IS THE STUDY CLINICALLY NECESSARY? Yes
AC is a common disease. Any improvement in this field will benefit many patients reducing
morbidity, mortality, conversion rate, operation time, hospital stay, postoperative pain,
return to normal activity and aesthetic result. All our patients will be informed about the
study and an informed consent will be obtained. There will not be inconveniences caused to
the patients. All the medical informations obtained from the patients will be kept
confidentially among the research scientists conducting the study. The patients will be free
to withdrawn from the study, whenever they want without any obligation.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03636841 -
Reduction of Operating Time by a Smoke Electroprecipitation Device for Acute Cholecystitis
|
N/A | |
Completed |
NCT02379780 -
Ultrasound Guided Subcostal Transversus Abdominis Plane Versus Paravertebral Block in the Laparoscopic Cholecystectomy
|
N/A | |
Completed |
NCT02461147 -
Prospective Validation of "Cholecystectomy First" Strategy for Gallstone Migration
|
||
Completed |
NCT02264444 -
Establishing Visualization Grading Scale on LESS Cholecystectomy
|
N/A | |
Completed |
NCT01937104 -
ONSD According to the Position During Laparoscopy
|
N/A | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT00940264 -
Laparoscopic Transvaginal Hybrid Cholecystectomy: a Prospective Data Collection.
|
N/A | |
Completed |
NCT00370344 -
Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease
|
Phase 2/Phase 3 | |
Completed |
NCT00195351 -
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection
|
Phase 4 | |
Completed |
NCT02858986 -
3D Versus 4K Laparoscopic Cholecystectomy
|
N/A | |
Completed |
NCT04602156 -
US-guided Trocar Versus Seldiger Technique for Percutaneous Cholecystostomy
|
N/A | |
Completed |
NCT04942665 -
Low Dose ICG for Biliary Tract and Tumor Imaging
|
Phase 2 | |
Completed |
NCT02547064 -
Effect of Modified Stylet Angulation on the Intubation With GlideScope®
|
N/A | |
Completed |
NCT00230971 -
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
|
Phase 4 | |
Completed |
NCT04122261 -
A Clinical Study of Chinese Domestic Surgical Robot
|
N/A | |
Completed |
NCT04716166 -
Incentive Spirometry and Upper Abdominal Laparoscopic Surgery
|
N/A | |
Completed |
NCT01476319 -
Improving Informed Consent Process for Percutaneous Cholecystostomy in the Emergency Department
|
N/A | |
Withdrawn |
NCT02225418 -
Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy
|
N/A | |
Suspended |
NCT04306939 -
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
|
||
Completed |
NCT02782832 -
No Need for Neuromuscular Blockade in Daycase Laparoscopic Surgery
|